 |
Emmanuel Boucher
Schreiner MediPharm
|
Printing labels for pharmaceutical industry require a production process with no-fault quality insurance moreover when labels are dedicated for injection drugs.
Schreiner MediPharm has rapidly built high notoriety in implementing controls and especially in end of production line allowing visual verification of each label. Thus, this process has contributed to raise a relevant experience in export market like Japan, for which quality specifications are extremely demanding.
In fact, after several operations so call; « in process control », each labels reel is control by digital camera before release (see picture). This equipment is installed on a laminar flow station and allows verification label by label in order to check if there is any particle or printing default considered as a non conformity. With this high resolution camera, the system identify every smallest deviation and then computer software stop immediately the foil an move it back allowing the operator to remove the defect labels and replace it by a label previously control.
Drug and brand protection :
One of the biggest challenges in secondary and primary packaging is and will be anti counterfeiting.
The syringe label SecuMed2 can be defined as a “Must” to demonstrate all different functionalities or added values which can be implemented on such a very small label. Indeed, this label shows 2 detachable parts on which can be post printed a bar codes (Data Matrix, RSS 14, etc…). A window allows visual control of the liquid when its construction gives added space for a large quantity of text.
Concerning security, 2 different types of features can be implemented; overt and covert (or semi covert). Generally speaking, overt features are dedicated for authentication by a large public (patient, physician, pharmacist, etc…) when covert features are mainly targeting experts or in order to verify the drug origin. Among the used technologies; holographic effects, Color Shift Effect, thermal reactive ink, etc… with also other confidential elements like laser pen and DNA.
Protection for end user :
In the FDA regulatory context against needle injuries (evaluated at 500 000/an only in Germany), some laboratories have decided to integrate a device on their syringe in order to secure needle after injection (safety device). This increasing tendancy has initiated the idea of implementing on a label a stripe with a plastic catcher allowing to secure the needle (only on needle stick in syringe) before putting to waste; Needle-Trap. This really specific label is not considered as a « safety device » but obviously its goal is to protect end user from needle injury when manipulating the syringe after drug administration (so call active system). Needle Trap can de display by regular labeling machine (with some small modifications) and allow reaching high speed cadencies. Needle-Trap has been awarded by FINAT when the FDA has approved this system by a procedure called 510k, giving approval to use it on US market…before its launch in Europe coming soon…
|
|
to be read :
| | Tuesday, June 16th 2009 |  |
| | Tuesday, June 16th 2009 | |
| | Monday, September 14th 2009 | |
| | Monday, November 2nd 2009 | |
| | Monday, October 26th 2009 | |
| | Monday, November 9th 2009 | |
|
Home 
Connect
